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c-di-GMP is a major secondary-messenger molecule in regulation of bacterial
pathogenesis. Therefore, the c-di-GMP-mediated signal transduction network is
of considerable interest. The PilZ domain was the first c-di-GMP receptor to be
predicted and identified. However, every PilZ domain binds c-di-GMP with a
different binding affinity. Intriguingly, a noncanonical PilZ domain has recently
been found to serve as a mediator to link FimXEAL to the PilB or PilTATPase to
control the function of type IV pili (T4P). It is thus essential to determine the
structure of the FimXEAL–PilZ complex in order to determine how the binding
of c-di-GMP to the FimXEAL domain induces conformational change of the
adjoining noncanonical PilZ domain, which may transmit information to PilB
or PilT to control T4P function. Here, the preparation and preliminary X-ray
diffraction studies of the XccFimXEAL–c-di-GMP and XccFimXEAL–c-di-GMP–
XccPilZ complexes from Xcc (Xanthomonas campestris pv. campesteris) are
reported. Detailed studies of these complexes may allow a more thorough
understanding of how c-di-GMP transmits its effects through the degenerate
EAL domain and the noncanonical PilZ domain.
1. Introduction
Cyclic di-GMP (c-di-GMP) was first identified as a positive allosteric
effector of cellulose synthase in the bacterium Acetobacter xylinum
more than 20 years ago (Ross et al., 1987, 1990), but has recently
emerged as an important secondary messenger that controls a variety
of cellular activities, such as the biogenesis of biofilms, flagella and
pili in diverse bacteria. These activities have been correlated with
bacterial pathogenicity (Ro¨mling et al., 2005; Jenal & Malone, 2006;
Ro¨mling & Amikam, 2006). Diguanylate cyclases (DGCs) containing
the GGDEF domain and phosphodiesterases (PDEs) containing the
EAL domain (Tal et al., 1988; Simm et al., 2004; Tischler & Camilli,
2004; Ro¨mling et al., 2005) or the HD-GYP domain (Slater et al.,
2000; Ryan et al., 2006) are responsible for the synthesis and degra-
dation of c-di-GMP, respectively. However, it is still unclear how
many targets of c-di-GMP are available and how this important
secondary messenger mediates signal transduction in the cell. The
components and responses of c-di-GMP signalling pathways are hot
topics that are still being actively pursued (Ro¨mling, 2011).
PilZ-domain-containing proteins were suggested to be c-di-GMP
receptors by a bioinformatics study (Amikam & Galperin, 2006) and
this was subsequently demonstrated to be the case by several
biochemical and structural studies (Ryjenkov et al., 2006; Merighi et
al., 2007; Pratt et al., 2007; Ramelot et al., 2007). However, two types
of PilZ domains were soon discovered: a type I PilZ domain that
contains conserved RXXXR and D/NXSXXG signature motifs in
the N-terminal region and experiences considerable conformational
changes upon c-di-GMP binding (Benach et al., 2007), and a type II
PilZ domain that lacks such signature motifs and is unable to bind
c-di-GMP directly. PA2960 from Pseudomonas aeruginosa is possibly
the best known type II protein and is the first PilZ domain (Alm et al.,
1996) known to be required for T4P-mediated twitching mobility
(Mattick, 2002). In Xanthomonas campestris pv. campesteris (Xcc),
four PilZ-domain proteins were discovered and were found to be
essential for its pathogenicity (McCarthy et al., 2008); two of them
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contain a regular type I sequence and the other two contain a type
II noncanonical sequence. XCC1028 is one of the type II domain-
containing proteins; it adopts a similar five-stranded -barrel struc-
ture, yet exhibits considerable differences at the N-terminal end
owing to a lack of the characteristic N-terminal c-di-GMP binding
signature motifs (Li, Chin, Liu et al., 2009). XCC6012 is another
example; it adopts a monomer structure similar to that of XCC1028,
yet is interrupted in the middle by two extra long helices between the
1 and 2 strands and self-assembles into a tetramer via the extra
3 heptad-repeat helix (Li et al., 2011). How type II PilZ domains
respond to the c-di-GMP signal remains unclear to date.
FimX is a large multi-domain protein containing a tandem of REC,
PAS, GGDEF and EAL domains that governs bacterial twitching
motility (Huang et al., 2003; Kazmierczak et al., 2006). Interestingly,
the REC, GGDEF and EAL domains in FimX are all degenerate:
the REC domain lacks the crucial Asp essential for phosphotransfer,
the GGDEF domain contains a rather unusual GDSIF motif and
the EAL domain contains a modified EVL motif at the active site.
Several biochemical and structural analyses have revealed the role of
the degenerate EAL domain as the high-affinity binding receptor of
c-di-GMP (Navarro et al., 2009; Qi et al., 2011). The crystal structure
of a degenerate EAL domain from P. aeruginosa has also been solved
(Navarro et al., 2009).
Recently, a detailed study of the interaction between the FimXEAL
and PilZ domains from Xac (X. axonopodis pv. citri) has been carried
out using a variety of techniques such as NMR, thermal melting, far-
Western blotting and in vivo motility assay methods (Guzzo et al.,
2009). From these studies, it was concluded that XacPilZ binds to
the XacPilB ATPase required for T4P polymerization and to the
XacFimXEAL domain required for binding c-di-GMP to regulate T4P
biogenesis. However, the crucial FimXEALPilZ complex structure is
not available to date. Since the sequence and structure of XacPilZ
were found to be identical to those of XccPilZ1028 (Guzzo et al., 2009;
Li, Chin, Liu et al., 2009), and the FimXEAL sequences from both Xcc
and Xac align very well with an identity of 90.9% and a similarity of
93.3% (data not shown), a similar interaction between the FimXEAL
and PilZ domains is very likely to exist in Xcc. Here, we report the
expression, purification, crystallization and preliminary X-ray
diffraction studies of the XccFimXEAL–c-di-GMP and XccFimXEAL–
c-di-GMP–XccPilZ1028 complexes from Xcc. This phytopathogen is
ideal for studying c-di-GMP-related issues since it contains a
considerable number of GGDEF-domain, EAL-domain, HD-GYP-
domain and PilZ-domain proteins (Ryan et al., 2007; McCarthy et al.,
2008). Detailed studies of the XccFimXEAL–c-di-GMP and XccFim-
FimXEAL–c-di-GMP–XccPilZ complexes may allow a more thorough
understanding of how c-di-GMP transmits its effects through non-
canonical PilZ-domain proteins.
2. Materials and methods
2.1. Reagents
c-di-GMP was produced by an enzymatic method using an altered
thermophilic DGC enzyme as described previously (Rao et al., 2009).
2.2. Cloning and purification
XccFimXEAL was PCR-amplified directly from the plant pathogen
X. campestris pv. campestris strain 17 (Xcc) using the forward primer
50-TACTTCCAATCCAATGCTGAGGAAGAACGCATCGAGCG-
C-30 and the reverse primer 50-TTATCCACTTCCAATGCTAGTA-
GTCGCCCGGCCACCCGCG-30. The PCR fragment exhibited the
correct size in an agarose-gel electrophoresis experiment and was
confirmed by DNA sequencing. A ligation-independent cloning
(LIC) approach (Aslanidis & de Jong, 1990; Stols et al., 2001; Wu et al.,
2005) was used to obtain the desired constructs. The final construct
codes for an N-terminal His6 tag, a 17-amino-acid linker and the
XccFimXEAL target under the control of a T7 promoter. Over-
expression of the His6-tagged target protein was induced by the
addition of 800 ml 500 mM IPTG to the medium solution (to give a
final IPTG concentration of 0.5 mM) at 293 K for 18 h. The target
protein was purified by immobilized metal-affinity chromatography
(IMAC) on a nickel column (Sigma) equilibrated with a buffer
consisting of 20 mM Tris–HCl pH 8.0, 80 mM NaCl. The target
protein was eluted with a gradient of 50–300 mM imidazole in the
same buffer. The fractions containing XccFimXEAL were monitored
using 13% SDS–PAGE and recombined. The His6 tag and linker
were then cleaved from the XccFimXEAL target using TEV (tobacco
etch virus) protease at 289 K for 10 h. For crystallization, the
XccFimXEAL protein was further purified on a Sephadex gel-filtration
column (A¨KTA, Pharmacia Inc.). The final target-protein sample
exhibited a purity greater than 99% as revealed by SDS–PAGE gel
analysis (Fig. 1). It contained only an extra tripeptide (SNA) from
the vector at the N-terminal end. SeMet-labelled XccFimXEAL was
prepared in a similar way, except that it was produced using a non-
auxotroph Escherichia coli strain BL21 (DE3) as host in the absence
of methionine but with ample amounts of SeMet (100 mg l1). The
M9 medium consisted of 1 g ammonium chloride, 3 g KH2PO4, 6 g
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Figure 1
(a) The domain architecture and constructs used in these studies. (b) SDS–PAGE
(13%) monitoring of the overexpression and purification of XccFimXEAL. Lane 1,
protein markers (labelled in kDa); lane 2, whole cell lysate before IPTG induction;
lane 3, whole cell lysate after IPTG induction; lane 4, supernatant of His6-tagged
XccFimXEAL; lane 5, gel-purified XccFimXEAL after TEV cleavage.
Na2HPO4 supplemented with 20%(w/v) glucose, 0.3%(w/v) MgSO4
and 10 mg FeSO4 in 1 l double-distilled water. Induction was
sustained at 293 K for 18 h by the addition of 0.45 ml 0.5 mM IPTG.
The purification of the SeMet-labelled XccFimXEAL protein was
performed using the same procedure as for the native protein.
The XccPilZ1028 sample was obtained using a similar protocol to
that previously published (Li, Chin, Shih et al., 2009).
2.3. Crystallization
For crystallization, the native XccFimXEAL protein was concen-
trated to 0.56 mM in 20 mM Tris–HCl pH 8.0, 80 mM sodium chloride
using an Amicon Ultra-10 (Millipore). The SeMet-XccFimXEAL–
XccPilZ1028 complex (1:1 ratio) was concentrated to 0.075 mM in a
similar way. Appropriate volumes of 25.6 mM c-di-GMP were added
to the XccFimXEAL and SeMet-XccFimXEAL–XccPilZ1028 complex
solutions to prepare samples for cocrystallization with a 2:1 ligand:
protein ratio. Screening for crystallization conditions for each protein
was performed using sitting-drop vapour diffusion in 96-well plates
(Hampton Research) at 277 K by mixing 0.5 ml protein solution with
0.5 ml reservoir solution and equilibrating against 50 ml reservoir
solution. Initial screens including the sparse-matrix Crystal Screen
and Crystal Screen 2 (Hampton Research), a systematic PEG–pH
screen and the PEG/Ion screen (Hampton Research) were performed
using a Gilson C240 crystallization workstation. Cubic crystals of the
XccFimXEAL–c-di-GMP complex appeared in 7 d from drops equi-
librated against 50 ml reservoir solution comprising 20% PEG 3350,
0.2M sodium formate pH 7.2, while hexagonal crystals of the SeMet-
XccFimXEAL–c-di-GMP–XccPilZ1028 complex appeared in 21 d from
drops equilibrated against 50 ml reservoir solution comprising 0.2M
NaCl, 0.1M HEPES pH 7.5, 20% PEG 3K (Fig. 2). Crystals of both
complexes suitable for diffraction experiments were grown from
drops by mixing 1.5 ml protein solution with 1.5 ml reservoir solution
and equilibrating against 500 ml reservoir solution at 277 K. Crystals
of the XccFimXEAL–c-di-GMP complex reached dimensions of 0.2 
0.2 0.2 mm after one week, while those of the SeMet-XccFimXEAL–
c-di-GMP–XccPilZ1028 complex reached dimensions of 0.01  0.01 
0.01 mm after three weeks.
2.4. Data collection and processing
Crystals of both complexes were flash-cooled at 100 K under a
stream of cold nitrogen gas using the reservoir solution as cryopro-
tectant. Before data collection, the crystals were scanned for Se
absorption and 0.97934 A˚was found to be the peak wavelength of the
anomalous signal. X-ray diffraction data for the native XccFimXEAL–
c-di-GMP complex were obtained to 2.5 A˚ resolution on beamline
13B1 at the National Synchrotron Radiation Research Center
(NSRRC), Taiwan, while those for the SeMet-XccFimXEAL–c-di-
GMP–XccPilZ1028 complex were collected to 2.7 A˚ resolution on
beamline 12B2 at SPring-8, Japan (Fig. 3). The data were indexed and
integrated using the HKL-2000 processing software (Otwinowski &
Minor, 1997), generating data sets that were 97.1 and 99.4% complete
with an overall Rmerge of 3.6 and 13.8% on intensities, respectively.
Determination and refinement of the selenium positions, phase
calculation and density modification were carried out using the
programs SOLVE and RESOLVE (Terwilliger & Berendzen, 1999).
Molecular replacement was performed using CNS (Bru¨nger et al.,
1998). The crystals of the XccFimXEAL–c-di-GMP complex belonged
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Figure 2
Crystals of theXccFimXEAL–c-di-GMP and SeMet-XccFimXEAL–c-di-GMP–XccPilZ1028 complexes. (a) XccFimX
EAL–c-di-GMP crystals grown in 0.2M sodium formate pH
7.2, 20% PEG 3350 using the hanging-drop vapour-diffusion method at 277 K. These crystals reached average dimensions of 0.2  0.2  0.2 mm after one week. (b) SeMet-
XccFimXEAL–c-di-GMP–XccPilZ1028 crystals grown in 0.1M HEPES pH 7.5, 0.2M NaCl, 20% PEG 3K using the hanging-drop vapour-diffusion method at 277 K. These
crystals reached average dimensions of 0.01  0.01  0.01 mm after three weeks.
Table 1
Summary of the native and Se-SAD crystallographic data for the XccFimXEAL–
c-di-GMP and SeMet-XccFimXEAL–c-di-GMP–XccPilZ1028 complexes.
Values in parentheses are for the outermost shell.
XccFimXEAL–c-di-GMP
SeMet-XccFimXEAL–
c-di-GMP–XccPilZ1028†
Native Peak
Beamline NSRRC BL13B1 Spring-8
Wavelength (A˚) 1.00000 0.97934
Space group P3221 P6322
Unit-cell parameters (A˚, ) a = b = 65.67, c = 121.29,
 = 120
a = b = 158.22, c = 64.81,
 = 120
Resolution range (A˚) 30–2.5 (2.59–2.50) 30–2.7 (2.80–2.70)
Total reflections 68379 (5890) 189837 (16170)
Unique reflections 19685 (1899) 49419 (4899)
Multiplicity 3.5 (3.1) 3.8 (3.3)
Completeness (%) 97.1 (93.5) 99.4 (98.7)
Rmerge‡ (%) 3.6 (22.1) 13.8 (55.2)
hI/(I)i 30.5 (5.4) 7.8 (1.8)
Matthews coefficient (A˚3 Da1) 2.74 2.93
Solvent content (%) 55.2 58.0
† The FOM (figure of merit) for the SAD data for this complex was 0.37. ‡ Rmerge =P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith intensity measure-
ment of reflection hkl, including symmetry-related reflections, and hI(hkl)i is its
average.
to space group P3221, while those of the XccFimX
EAL–c-di-GMP–
XccPilZ1028 complex belonged to space group P6322. The diffraction
statistics are summarized in Table 1.
3. Results and discussion
In this manuscript, we report the successful cloning, protein expres-
sion and purification of the XccFimXEAL and XccPilZ1028 proteins
and the crystal screening and preliminary X-ray data analyses of the
nativeXccFimXEAL–c-di-GMP and SeMet-substituted XccFimXEAL–
c-di-GMP–XccPilZ1028 complexes. Since the FimX protein is a large
bacterial protein containing a tandem of REC, PAS, GGDEF and
EAL domains, we tried to construct clones from different combina-
tions of these domains as shown in Fig. 1(a) in order to express the
domains and determine their structures using X-ray crystallography.
Unfortunately, most of these constructs gave proteins in inclusion
bodies and onlyXccFimXEAL gave soluble protein. As shown in Fig. 1,
the His6 tag and linker of the XccFimX
EAL target could be success-
fully cleaved by TEV (tobacco etch virus) protease at 289 K for 10 h
to obtain target protein that is more than 99% pure. It contains only
an extra tripeptide (SNA) at the N-terminal end after further gel-
filtration chromatography. However, in the absence of c-di-GMP no
crystal formation was observed for the XccFimXEAL domain and
only a poor diffraction pattern was detected for the XccFimXEAL–
XccPilZ1028 complex even though it formed seemingly good crystals.
These results indicated that c-di-GMP was crucial in forming compact
crystals for both the XccFimXEAL domain and the XccFimXEAL–
XccPilZ1028 complex.
We were surprised by the apparent existence of data to higher
resolution once data collection for the nativeXccFimXEAL-c-di-GMP
complex began (Table 1) and are considering an experimental effort
to collect these data for refinement of the structure at higher reso-
lution.
Interestingly, although the EAL-domain structure has been solved
and found to be conserved (Minasov et al., 2009; Navarro et al., 2009;
Tchigvintsev et al., 2010), we were unable to solve the crystal structure
of XccFimXEAL–c-di-GMP using a molecular-replacement approach.
Fortunately, we were able to crystallize the XccFimXEAL–XccPilZ1028
complex using an SeMet-substituted XccFimXEAL domain in the
presence of c-di-GMP. Although the resolution of the SeMet-
XccFimXEAL–c-di-GMP–XccPilZ1028 complex was a little poorer
(2.7 A˚) than that of native XccFimXEAL–c-di-GMP (2.5 A˚), it should
be possible to perform successful phasing of the protein using an
Se-SAD approach based on the figure-of-merit statistic (Table 1).
Indeed, the model of the XccFimXEAL domain in the SeMet-
XccFimXEAL–c-di-GMP–XccPilZ1028 complex was almost complete
and the initial structure of XccFimXEAL was used as a model for
molecular replacement to determine the phases of the XccFimXEAL–
c-di-GMP complex. The Matthews coefficient and solvent content
were 2.74 A˚3 Da1 and 55.2%, respectively, for the XccFimXEAL–
c-di-GMP complex and 2.93 A˚3 Da1 and 58.0%, respectively, for the
SeMet-XccFimXEAL–c-di-GMP–XccPilZ1028 complex. The c-di-GMP
was clearly identified in the electron-density maps of both the
XccFimXEAL–c-di-GMP and the SeMet-XccFimXEAL–c-di-GMP–
XccPilZ1028 complexes. Refinement of both complexes is now in
progress.
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Figure 3
Diffraction patterns of the native XccFimXEAL–c-di-GMP and SeMet-XccFimXEAL–-c-di-GMP–XccPilZ1028 complexes collected on a MAR CCD system using synchrotron
radiation on the 13B1 beamline at NSRRC in Taiwan and the BL12B1 beamline at SPring-8 in Japan. The exposure time was 1 s, the oscillation range was 1 per frame and
the crystal-to-detector distance was 250 mm. The edge of the detector corresponds to a resolution of 2.5 and 3.2 A˚, respectively.
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